Jane Street’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74K Sell
11,900
-53,200
-82% -$308K ﹤0.01% 10777
2026
Q2
$396K Buy
65,100
+37,100
+133% +$891K ﹤0.01% 8561
2026
Q1
$712K Sell
28,000
-3,300
-11% -$93.4K ﹤0.01% 7244
2025
Q4
$657K Buy
31,300
+8,900
+40% +$145K ﹤0.01% 7102
2025
Q3
$346K Buy
+22,400
New +$321K ﹤0.01% 8635

Other funds holding RGC

Jane Street's RGC Position: Q3 2026 in Review

Jane Street reduced its Regencell Bioscience (RGC) stake by 17% in Q3 2026, selling an estimated $96.3K and leaving 81,697 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #7983.

Jane Street first reported a position in RGC in Q3 2025 and has held it in 3 quarters since. The position peaked at $599K in Q2 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Jane Street held 81,697 shares of Regencell Bioscience worth $508K as of Q3 2026.
  • Jane Street sold 16,651 Regencell Bioscience shares in Q3 2026, an estimated $96.3K.
  • Regencell Bioscience made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7983 holding.
  • Jane Street first reported a position in Regencell Bioscience in Q3 2025 and has held it in 3 quarters since.
  • Jane Street's Regencell Bioscience position peaked at $599K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.